BMRN
Price
$55.43
Change
-$0.14 (-0.25%)
Updated
Oct 3 closing price
Capitalization
10.64B
17 days until earnings call
COYA
Price
$6.10
Change
+$0.23 (+3.92%)
Updated
Oct 3 closing price
Capitalization
102.03M
31 days until earnings call
Interact to see
Advertisement

BMRN vs COYA

Header iconBMRN vs COYA Comparison
Open Charts BMRN vs COYABanner chart's image
BioMarin Pharmaceutical
Price$55.43
Change-$0.14 (-0.25%)
Volume$2.36M
Capitalization10.64B
Coya Therapeutics
Price$6.10
Change+$0.23 (+3.92%)
Volume$67.39K
Capitalization102.03M
BMRN vs COYA Comparison Chart in %
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMRN vs. COYA commentary
Oct 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a StrongBuy and COYA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 05, 2025
Stock price -- (BMRN: $55.43 vs. COYA: $6.10)
Brand notoriety: BMRN and COYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 103% vs. COYA: 86%
Market capitalization -- BMRN: $10.64B vs. COYA: $102.03M
BMRN [@Biotechnology] is valued at $10.64B. COYA’s [@Biotechnology] market capitalization is $102.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileCOYA’s FA Score has 0 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • COYA’s FA Score: 0 green, 5 red.
According to our system of comparison, both BMRN and COYA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 4 TA indicator(s) are bullish while COYA’s TA Score has 5 bullish TA indicator(s).

  • BMRN’s TA Score: 4 bullish, 5 bearish.
  • COYA’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, both BMRN and COYA are a bad buy in the short-term.

Price Growth

BMRN (@Biotechnology) experienced а +2.93% price change this week, while COYA (@Biotechnology) price change was +11.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.93%. For the same industry, the average monthly price growth was +13.10%, and the average quarterly price growth was +80.18%.

Reported Earning Dates

BMRN is expected to report earnings on Oct 22, 2025.

COYA is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMRN($10.6B) has a higher market cap than COYA($102M). COYA YTD gains are higher at: 6.461 vs. BMRN (-15.670). BMRN has higher annual earnings (EBITDA): 934M vs. COYA (-22.59M). BMRN has more cash in the bank: 1.43B vs. COYA (29.8M). BMRN has higher revenues than COYA: BMRN (3.06B) vs COYA (423K).
BMRNCOYABMRN / COYA
Capitalization10.6B102M10,392%
EBITDA934M-22.59M-4,134%
Gain YTD-15.6706.461-243%
P/E Ratio16.35N/A-
Revenue3.06B423K724,350%
Total Cash1.43B29.8M4,805%
Total Debt604MN/A-
FUNDAMENTALS RATINGS
BMRN: Fundamental Ratings
BMRN
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
65
PRICE GROWTH RATING
1..100
79
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMRNCOYA
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
59%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
56%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
62%
Bearish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 4 days ago
59%
Bullish Trend 3 days ago
88%
Declines
ODDS (%)
Bearish Trend 13 days ago
62%
Bearish Trend 13 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
71%
Bearish Trend 3 days ago
85%
Aroon
ODDS (%)
Bearish Trend 3 days ago
60%
Bearish Trend 3 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PAOTF12.851.48
+13.02%
Parrot Sa
UPMMY27.680.14
+0.51%
UPM-Kymmene Corp.
EXCH58.31N/A
N/A
Exchange Bankshares, Inc.
VGPBF108.22N/A
N/A
VGP SA
VIIQ0.20N/A
N/A
VisitIQ Corp.

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with TECH. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
-0.25%
TECH - BMRN
48%
Loosely correlated
+1.39%
SYRE - BMRN
47%
Loosely correlated
-0.56%
JAZZ - BMRN
46%
Loosely correlated
+1.65%
ROIV - BMRN
45%
Loosely correlated
+1.19%
IDYA - BMRN
45%
Loosely correlated
+1.62%
More

COYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, COYA has been loosely correlated with KNSA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if COYA jumps, then KNSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COYA
1D Price
Change %
COYA100%
+3.92%
KNSA - COYA
42%
Loosely correlated
+2.72%
GANX - COYA
39%
Loosely correlated
+3.23%
TRDA - COYA
36%
Loosely correlated
+1.35%
BMRN - COYA
34%
Loosely correlated
-0.25%
XNCR - COYA
34%
Loosely correlated
-0.42%
More